Refresh

Dr. Reddy's Laboratories Ltd.

Price on BSE   22 Jan,14:39 LIVE
1,218.20
+62.70
(+5.43%)

© 2026 Rediff.com
  • Volume :
  • 714,730.00
  • Prev Close :
  • 1,155.50
  • Day's H/L (Rs.) :
  • 1,225.00 - 1,188.95
  • 52wk H/L (Rs.) :
  • 1,377.95 - 1,025.90
  • Mkt Cap (Rs. Cr) :
  • 101,670.98
Price on NSE   22 Jan,15:18 LIVE
1,218.40
+61.20
(+5.29%)

© 2026 Rediff.com
  • Volume :
  • 6,057,616.00
  • Prev Close :
  • 1,157.20
  • Day's H/L (Rs.) :
  • 1,225.00 - 1,187.70
  • 52wk H/L (Rs.) :
  • 1,379.70 - 1,020.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com   1 hour(s) ago
Domestic sales a booster dose for pharma revenues
Rediff.com   3 day(s) ago
Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud
Rediff.com   10 Nov 2025
'India Should Move Quickly As Conditions Change'
Rediff.com   02 Jan 2026
Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com   22 Dec 2025
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
18.01
EPS (Rs.)
64.14
Sales (Rs. Cr)
4,618.60
Face Value (Rs.)
1
Net Profit Margin(%)
23.14
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
18.53

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr
Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.
Jan 21, 2026 18:20
Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact
Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.
Dec 08, 2025 14:49
Dr Reddy''s Biosimilar Approved in Europe
Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.
Nov 24, 2025 17:22
Dr Reddy''s Srikakulam Unit Gets USFDA VAI
Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.
Oct 21, 2025 12:46
Glenmark, Dr Reddy''s Recall Products in US: USFDA
Glenmark and Dr Reddy''s recall products in the US due to manufacturing issues, says USFDA. Recalls include oral contraceptives and muscle relaxants.
Oct 19, 2025 10:20

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

Radico Khaitan Q3 Profit Up 63% to Rs 155 Cr
Radico Khaitan reports 63% jump in Q3 profit to Rs 155 cr, driven by strong IMFL volume & premium brands. Revenue up 22%.
Jan 22, 2026 15:02
Infra Spending: Industry Urges Doubling in Budget
Industry leaders urge govt to double infrastructure spending to Rs 3 lakh cr in Budget for economic growth & job creation.
Jan 22, 2026 14:56
Smriti Irani's Gender Alliance Attracts Funds in Davos
Smriti Irani-led gender alliance in Davos secures \$2M for women-owned businesses. Focus on gender equity, women's wellness, and economic empowerment.
Jan 22, 2026 14:47
India Top Passenger Market for Singapore Changi Airport
India is a top passenger market for Singapore's Changi Airport. Airport added Vijayawada as new destination. Read more.
Jan 22, 2026 14:30
Indian Bank Q3 Profit Up 7% to Rs 3,061 Cr
Indian Bank reports a 7.33% rise in net profit to Rs 3,061 crore for Q3 December 2025. Gross NPAs improve. Total deposits increase by 12.62%.
Jan 22, 2026 14:30

More News »

Top News

Gold & Silver Futures Fall on Profit Booking
Gold and silver futures prices decline as investors book profits amid easing geopolitical tensions and a stronger US dollar.
Jan 22, 2026 15:06
Radico Khaitan Q3 Profit Up 63% to Rs 155 Cr
Radico Khaitan reports 63% jump in Q3 profit to Rs 155 cr, driven by strong IMFL volume & premium brands. Revenue up 22%.
Jan 22, 2026 15:02
Infra Spending: Industry Urges Doubling in Budget
Industry leaders urge govt to double infrastructure spending to Rs 3 lakh cr in Budget for economic growth & job creation.
Jan 22, 2026 14:56
Smriti Irani's Gender Alliance Attracts Funds in Davos
Smriti Irani-led gender alliance in Davos secures \$2M for women-owned businesses. Focus on gender equity, women's wellness, and economic empowerment.
Jan 22, 2026 14:47
India Top Passenger Market for Singapore Changi Airport
India is a top passenger market for Singapore's Changi Airport. Airport added Vijayawada as new destination. Read more.
Jan 22, 2026 14:30

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com